Show simple item record

EXTRACORPOREAL CYTOKINE HEMADSORPTION FOR THE TREATMENT OF REFRACTORY SEPTIC SHOCK. REPORT OF TWO CASES.

Adsorción extracorpórea de citoquinas en el tratamiento del shock séptico refractario. Casos clínicos

dc.contributoren-US
dc.contributores-ES
dc.creatorRathkamp, Mario; Hospital de urgencias asistencia pública (HUAP)
dc.creatorTomicic, Vinko; Hospital de Urgencias Asistencia Pública (HUAP)
dc.creatorCornejo, Juán; Hospital de urgencias asistencia pública (HUAP)
dc.creatorCruz, Pablo; Hospital de urgencias asistencia pública (HUAP)
dc.date2018-06-22
dc.date.accessioned2019-11-11T18:28:18Z
dc.date.available2019-11-11T18:28:18Z
dc.identifierhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/view/6744
dc.identifier.urihttps://revistaschilenas.uchile.cl/handle/2250/111524
dc.descriptionIf Septic shock (SS) evolves to refractory SS, mortality could reach 90%, despite giving an optimal treatment. Nowadays, extracorporeal devices which adsorb inflammatory cytokines are available, reducing the systemic inflammatory response syndrome. These devices can be used with continuous renal replacement therapy or conventional hemodialysis. We report two diabetic females aged 50 and 58 years, who underwent a total colectomy and amputation of diabetic foot and who developed a SS with high requirements of vasoactive drugs (norepinephrine and adrenaline) to maintain a mean arterial pressure of about 60 mmHg. Both were subjected to hemodialysis, connected to a cytokine hemadsorption device. The most important finding was the progressive reduction of vasopressor doses, effect that was observed nine hours after the beginning of the hemadsorption and lasted until its removal at 26 hours. Both patients survived.en-US
dc.descriptionIf Septic shock (SS) evolves to refractory SS, mortality could reach 90%, despite giving an optimal treatment. Nowadays, extracorporeal devices which adsorb inflammatory cytokines are available, reducing the systemic inflammatory response syndrome. These devices can be used with continuous renal replacement therapy or conventional hemodialysis. We report two diabetic females aged 50 and 58 years, who underwent a total colectomy and amputation of diabetic foot and who developed a SS with high requirements of vasoactive drugs (norepinephrine and adrenaline) to maintain a mean arterial pressure of about 60 mmHg. Both were subjected to hemodialysis, connected to a cytokine hemadsorption device. The most important finding was the progressive reduction of vasopressor doses, effect that was observed nine hours after the beginning of the hemadsorption and lasted until its removal at 26 hours. Both patients survived.es-ES
dc.formatapplication/pdf
dc.languagespa
dc.publisherRevista Médica de Chilees-ES
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/view/6744/4074
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/6744/34857
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/6744/34858
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/6744/34859
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/6744/34860
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/6744/34864
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/6744/34913
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/6744/34946
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/6744/34947
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/6744/34948
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/6744/34949
dc.sourceRevista Médica de Chile; Vol. 146, núm. 6 (2018): JUNIO 2018es-ES
dc.source0034-9887
dc.subjectCatecholamines; Cytokines; Hemadsorption; Shock, Septicen-US
dc.subjectCatecholamines; Cytokines; Hemadsorption; Shock, Septices-ES
dc.titleEXTRACORPOREAL CYTOKINE HEMADSORPTION FOR THE TREATMENT OF REFRACTORY SEPTIC SHOCK. REPORT OF TWO CASES.en-US
dc.titleAdsorción extracorpórea de citoquinas en el tratamiento del shock séptico refractario. Casos clínicoses-ES
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typees-ES


This item appears in the following Collection(s)

Show simple item record